Specialty Pipeline Development in Key and Unique Therapeutic Areas

Tuesday, October 1st | 1:30 pm Eastern

During this session, we will take a look into the near future of potential specialty drug releases, their potential impact, and what it means to patients, pharmacies, and payers. We will examine the landscape of drug development in pharmacy now and compare it to a time not too long ago. This webinar includes detailed discussions on Alzheimer’s Disease, Nonalcoholic Steatohepatitis (NASH), and Cystic Fibrosis.


Ryan J. Atkinson, PharmD, MBA
Senior Director of Specialty Pharmacy Strategy